Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.
Clinical trial NCT02596555 · TERMINATED
Trial details
- NCT number
- NCT02596555
- Sponsor
- Prof. Stavros Konstantinides, MD
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2020-02-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.